The largest database of trusted experimental protocols

Mir 665 inhibitor

Manufactured by GenePharma
Sourced in China

The MiR-665 inhibitor is a laboratory reagent designed to inhibit the activity of the miR-665 microRNA. It is a synthetic oligonucleotide that binds to and blocks the miR-665 molecule, preventing it from performing its regulatory functions in biological systems. This product is intended for research use only, and its specific applications should be evaluated by the end-user.

Automatically generated - may contain errors

5 protocols using mir 665 inhibitor

1

Silencing LIMT and Modulating miR-665 in Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
LIMT siRNAs (LIMT siRNA1:LIMT siRNA2:LIMT siRNA3=1:1:1), miR-665 siRNA, miR-665 mimics, miR-665 inhibitor and their corresponding negative controls were designed and manufactured by GenePharma (Shanghai, China). Transfections were performed using lipofectamine 2000 (Invitrogen, Carlsbad, USA) according to the manufacturer’s protocol. The sequences are shown in
Table 1.

Table1The siRNA sequences used in this study

Name

Sequence

LIMT-homo-177

Sense: 5′-CCAUUCAUGUCAGCAGUUATT-3′;

Antisense: 5′-UAACUGCUGACAUGAAUGGTT-3′

LIMT-homo-295

Sense: 5′-GCAGAACGUGAGGGUGUAATT-3′

Antisense: 5′-UUACACCCUCACGUUCUGCTT-3′

LIMT-homo-888

Sense: 5′-GCUUCCAACCUCCAUUGCATT-3′;

Antisense: 5′-UGCAAUGGAGGUUGGAAGCTT-3′

miR-665 mimic

Sense: 5′-ACCAGGAGGCUGAGGCCCCU-3′;

Antisense: 5′-GGGCCUCAGCCUCCUGGUUU-3′

miR-665 inhibitor

5′-AGGGGCCUCAGCCUCCUGGU-3′;

+ Open protocol
+ Expand
2

Evaluating Molecular Regulation in TSCC

Check if the same lab product or an alternative is used in the 5 most similar protocols
Normal gingival epithelial cells (ATCC® PCS-200-014™) were acquired from the American Type Culture Collection (ATCC; Manassas, VA, USA) and cultured in minimum essential medium (Gibco; Thermo Fisher Scientific, Inc., Waltham, MA, USA) containing 10% fetal bovine serum (FBS; Gibco; Thermo Fisher Scientific). Dulbecco’s modified Eagle’s medium (DMEM; Gibco; Thermo Fisher Scientific) with 10% FBS was employed in the culture of the TSCC cell line CAL-27 (ATCC). The other two TSCC cell lines SCC-9 and SCC-15 were maintained in a 1:1 mixture of DMEM and Ham’s F12 medium (Gibco; Thermo Fisher Scientific) containing 10% FBS and 400 ng/mL hydrocortisone. All cells were incubated at 37°C in a humidified incubator supplied with 5% CO2.
Small interfering RNAs (siRNAs) for NOP14-AS1 (si-NOP14-AS1) and negative control (NC) siRNA (si-NC) were designed and offered by Shanghai GenePharma Co., Ltd. (Shanghai, China). The overexpressed high mobility group box 3 (HMGB3) plasmid pcDNA3.1-HMGB3 was constructed by RiboBio (Guangzhou, China). miRNA-665 (miR-665) mimic, NC mimic, miR-665 inhibitor, and NC inhibitor were also obtained from Shanghai GenePharma. TSCC cells were seeded into six-well plates, and transfection was performed by employing Lipofectamine 2000 (Invitrogen; Thermo Fisher Scientific).
+ Open protocol
+ Expand
3

Breast Cancer Cell Line Characterization

Check if the same lab product or an alternative is used in the 5 most similar protocols
A normal human breast epithelial cell line, MCF-10A and six human breast cancer cells T47D, MCF-7, MDA-MB-231, MDA-MB-415, ZR-75-1, and ZR-75-30 cell lines were maintained at the State Key Laboratory of Oncology in South China. MCF-10A cells were cultured in a complete growth medium (CM-0525, Procell Life Science & Technology Company, Wuhan, China). BC cells were maintained in Dulbecco’s modified Eagle medium (DMEM containing 4.5 g/L d-glucose) supplemented with 10% fetal bovine serum (FBS; Gibco, US) at 37 °C in a humidified incubator with an atmosphere of 5% CO2. The miR-665 mimics, miR-665 inhibitor, normal (scramble) control (NC) oligonucleotides, and the small interfering RNA (siRNA) targeting human NR4A3 mRNA were purchased from GenePharma (Shanghai, China). Cell transfection was performed using Lipofectamine™ 3000 transfection reagent (Invitrogen, USA) according to the manufacturer’s instructions.
+ Open protocol
+ Expand
4

Modulating lncRNA DCST1-AS1 in Endometrial Cancer

Check if the same lab product or an alternative is used in the 5 most similar protocols
Four human EC cell lines (HEC-1A, HEC-1B, RL-95-2, and JEC) and human normal endometrial stromal cells (HESCs) were obtained from the ATCC. Cells were cultured in Dulbecco’s modified Eagle’s medium (DMEM) (Gibco, Carlsbad, CA, USA) supplemented with 10% fetal bovine serum (FBS, Gibco) at 37°C in a 5% CO2 incubator. Two small interfering RNAs (siRNAs) targeting lncRNA DCST1-AS1, negative control siRNA (si-NC), miR-665 mimic, miR-873-5p mimic, control mimic (miR-NC), miR-665 inhibitor, miR-873-5p inhibitor, control inhibitor, pcDNA-HOXB5, pcDNA-CADM1, and empty vector (pcDNA3.1) were synthesized by GenePharma Co., Ltd. (Shanghai, China). Briefly, EC cells were seeded into six-well plates at 70% cell confluence. Cell transfection was conducted using Lipofectamine 2000 (Invitrogen, Carlsbad, CA, USA) according to the protocol of the manufacturer. After transfection, EC cells were cultured for the indicated time and subjected to the following experiments.
+ Open protocol
+ Expand
5

MiR-665 Modulation in SKOV3 and ES2 Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
miR-665 inhibitor (5′-AGGGGCCUCAGCCUCCUGGU-3′), miR-665 mimic (5′-ACCAGGAGGCUGAGGCCCCU-3′) and the corresponding negative controls (miR-NC; 5′-UCGCUUGGUGCAGGUCGGGAA-3′) were synthesized and purchased from Shanghai GenePharma Co., Ltd. SKOV3 and ES2 cells were seeded into each well of 24-well plates (2×105 cells per well) and were transfected with miR-665 inhibitor, miR-665 mimic, miR-NC inhibitor or miR-NC mimic at a concentration of 50 nM with Lipofectamine® 3000 (Invitrogen; Thermo Fisher Scientific, Inc.) following the manufacturer's protocol, and maintained for 48 h before any subsequent experiments were performed.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!